Samantha S M Drover1, Gro D Villanger2, Heidi Aase2, Thea S Skogheim2, Matthew P Longnecker3, R Thomas Zoeller4, Ted Reichborn-Kjennerud2, Gun P Knudsen2, Pål Zeiner5, Stephanie M Engel1. 1. From the Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC. 2. Norwegian Institute of Public Health, Physical and Mental health, Oslo, Norway. 3. National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, NC. 4. Biology Department, University of Massachusetts-Amherst, Amherst, MA. 5. Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Abstract
BACKGROUND: Attention deficit hyperactivity disorder (ADHD) is the most common neurobehavioral disorder in children, yet its etiology is poorly understood. Early thyroid hormone disruption may contribute to the development of ADHD. Disrupted maternal thyroid hormone function has been associated with adverse neurodevelopmental outcomes in children. Among newborns, early-treated congenital hypothyroidism has been consistently associated with later cognitive deficits. METHODS: We systematically reviewed literature on the association between maternal or neonatal thyroid hormones and ADHD diagnosis or symptoms. We searched Embase, Pubmed, Cinahl, PsycInfo, ERIC, Medline, Scopus, and Web of Science for articles published or available ahead of print as of April 2018. RESULTS: We identified 28 eligible articles: 16 studies of maternal thyroid hormones, seven studies of early-treated congenital hypothyroidism, and five studies of neonatal thyroid hormones. The studies provide moderate evidence for an association between maternal thyroid hormone levels and offspring ADHD, some evidence for an association between early-treated congenital hypothyroidism and ADHD, and little evidence for an association between neonatal thyroid hormone levels and later ADHD. CONCLUSIONS: The reviewed articles suggest an association between maternal thyroid function and ADHD, and possibly between early-treated congenital hypothyroidism and ADHD. Study limitations, however, weaken the conclusions in our systematic review, underlining the need for more research. Importantly, there was much variation in the measurement of thyroid hormone function and of ADHD symptoms. Recommendations for future research include using population-based designs, attending to measurement issues for thyroid hormones and ADHD, considering biologically relevant covariates (e.g., iodine intake), and assessing nonlinear dose-responses.
BACKGROUND:Attention deficit hyperactivity disorder (ADHD) is the most common neurobehavioral disorder in children, yet its etiology is poorly understood. Early thyroid hormone disruption may contribute to the development of ADHD. Disrupted maternal thyroid hormone function has been associated with adverse neurodevelopmental outcomes in children. Among newborns, early-treated congenital hypothyroidism has been consistently associated with later cognitive deficits. METHODS: We systematically reviewed literature on the association between maternal or neonatal thyroid hormones and ADHD diagnosis or symptoms. We searched Embase, Pubmed, Cinahl, PsycInfo, ERIC, Medline, Scopus, and Web of Science for articles published or available ahead of print as of April 2018. RESULTS: We identified 28 eligible articles: 16 studies of maternal thyroid hormones, seven studies of early-treated congenital hypothyroidism, and five studies of neonatal thyroid hormones. The studies provide moderate evidence for an association between maternal thyroid hormone levels and offspring ADHD, some evidence for an association between early-treated congenital hypothyroidism and ADHD, and little evidence for an association between neonatal thyroid hormone levels and later ADHD. CONCLUSIONS: The reviewed articles suggest an association between maternal thyroid function and ADHD, and possibly between early-treated congenital hypothyroidism and ADHD. Study limitations, however, weaken the conclusions in our systematic review, underlining the need for more research. Importantly, there was much variation in the measurement of thyroid hormone function and of ADHD symptoms. Recommendations for future research include using population-based designs, attending to measurement issues for thyroid hormones and ADHD, considering biologically relevant covariates (e.g., iodine intake), and assessing nonlinear dose-responses.
Authors: J E Haddow; G E Palomaki; W C Allan; J R Williams; G J Knight; J Gagnon; C E O'Heir; M L Mitchell; R J Hermos; S E Waisbren; J D Faix; R Z Klein Journal: N Engl J Med Date: 1999-08-19 Impact factor: 91.245
Authors: Offie Porat Soldin; Arvind K N Nandedkar; Knoxley M Japal; Mark Stein; Shiela Mosee; Phyllis Magrab; Shenghan Lai; Steven H Lamm Journal: Clin Biochem Date: 2002-03 Impact factor: 3.281
Authors: Eric Mick; Joseph Biederman; Stephen V Faraone; Julie Sayer; Seth Kleinman Journal: J Am Acad Child Adolesc Psychiatry Date: 2002-04 Impact factor: 8.829
Authors: Sunjay Sethi; Rhianna K Morgan; Wei Feng; Yanping Lin; Xueshu Li; Corey Luna; Madison Koch; Ruby Bansal; Michael W Duffel; Birgit Puschner; R Thomas Zoeller; Hans-Joachim Lehmler; Isaac N Pessah; Pamela J Lein Journal: Environ Sci Technol Date: 2019-03-19 Impact factor: 9.028
Authors: Elizabeth M Kamai; Gro D Villanger; Rachel C Nethery; Cathrine Thomsen; Amrit K Sakhi; Samantha S M Drover; Jane A Hoppin; Gun Peggy Knudsen; Ted Reichborn-Kjennerud; Pål Zeiner; Kristin Overgaard; Amy H Herring; Heidi Aase; Stephanie M Engel Journal: Environ Epidemiol Date: 2021-07-01
Authors: James B B Adams; Jacob C C Sorenson; Elena L L Pollard; Jasmine K K Kirby; Tapan Audhya Journal: Nutrients Date: 2021-05-28 Impact factor: 5.717